N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humans

This publication has 17 references indexed in Scilit:

• Drug metabolising N-acetyltransferase activity in human cell lines
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1991
• Expression of N-Acetyl Transferase in a Human Monocytic Cell-Line, U937
  Human & Experimental Toxicology, 1991
• Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
  Journal of Clinical Investigation, 1990
• Drug-Induced Immune-Complex Disease
  Complement and Inflammation, 1989
• [18] Cloning large segments of genomic DNA using cosmid vectors
  Published by Elsevier ,1987
• Use of high-performance liquid chromatography in the measurement of in vitro acetylation in man
  Journal of Chromatography A, 1986
• N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population
  Carcinogenesis: Integrative Cancer Research, 1985
• ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER
  The Lancet, 1982
• Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis
  The American Journal of Medicine, 1973
• Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.
  Journal of Clinical Investigation, 1965